| ALL | acute lymphocytic leukemia |
| AML | acute myeloid leukemia |
| BCMA | B-cell maturation antigen |
| CAR | chimeric antigen receptor |
| CLL | chronic lymphocytic leukemia |
| CRS | cytokine release storm |
| CSR | chimeric switch receptors |
| DLBCL | diffuse large B-cell lymphoma |
| DNR | dominant negative receptor |
| FDA | food and drug administration |
| HL | Hodgkin lymphoma |
| HSCT | hematopoietic stem cell transplant |
| HSPCs | hematopoietic stem and progenitor cells |
| MAPK | mitogen-activated protein kinase |
| MCL | mantle cell lymphoma |
| MHC | major histocompatibility complex |
| MM | multiple myeloma |
| NHL | Non-Hodgkin lymphomas |
| scFv | single-chain variable fragment |
| TAA | tumor-associated antigens |
| TanCAR | tandem CAR |
| T-cells | T-lymphocytes |
| TCR | T-cell receptor |
| TILs | tumor infiltrating lymphocytes |
| TME | tumor microenvironment |
| TRUCKS | T-cells redirected for universal cytokine killing |
| VEGF-A | vascular endothelial growth factor A |